Immatics (IMTX) Prepaid Assets (2019 - 2025)
Immatics (IMTX) posted Prepaid Assets of $33.3 million for Q4 2025, up 18.6% sequentially from $28.0 million in Q3 2025, and up 61.72% YoY from $20.6 million in Q4 2024.
Immatics (IMTX) Prepaid Assets (2019 - 2025) Analysis & Trends
Immatics has reported Prepaid Assets for 7 years, with the latest figure at $33.3 million in Q4 2025.
- Quarterly Prepaid Assets rose 61.72% year-over-year to $33.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $33.3 million (up 61.72% YoY) and the FY2025 annual result came in at $32.3 million, up 54.97% from the prior year.
- Prepaid Assets grew to $33.3 million in Q4 2025 per IMTX's latest filing, from $28.0 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $33.3 million in Q4 2025 and troughed at $5.7 million in Q1 2021.
- A 5-year average of $17.7 million and a median of $19.1 million in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2021 and 2023: Prepaid Assets decreased 6.06% in 2021, then jumped 123.19% in 2023.
- Over 5 years, Prepaid Assets stood at $7.3 million in 2021, then jumped by 92.59% to $14.1 million in 2022, then soared by 47.71% to $20.9 million in 2023, then dropped by 1.38% to $20.6 million in 2024, then jumped by 61.72% to $33.3 million in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $33.3 million, $28.0 million, and $26.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 33.26 Mn |
| Sep 30, 2025 | 28.04 Mn |
| Jun 30, 2025 | 26.93 Mn |
| Mar 31, 2025 | 25.46 Mn |
| Dec 31, 2024 | 20.57 Mn |
| Sep 30, 2024 | 21.20 Mn |
| Jun 30, 2024 | 27.14 Mn |
| Mar 31, 2024 | 24.62 Mn |
| Dec 31, 2023 | 20.85 Mn |
| Sep 30, 2023 | 20.11 Mn |
| Jun 30, 2023 | 18.15 Mn |
| Mar 31, 2023 | 16.11 Mn |
| Dec 31, 2022 | 14.12 Mn |
| Sep 30, 2022 | 11.94 Mn |
| Jun 30, 2022 | 11.40 Mn |
| Mar 31, 2022 | 7.22 Mn |
| Dec 31, 2021 | 7.33 Mn |
| Sep 30, 2021 | 7.31 Mn |
| Jun 30, 2021 | 5.80 Mn |
| Mar 31, 2021 | 5.75 Mn |